Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
ClinicalTrials.gov study NCT04712864. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04626908. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
ClinicalTrials.gov study NCT05963217. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignanci
ClinicalTrials.gov study NCT05887167. IPD Sharing: NO. Countries: 1. Publications: 0.
Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
ClinicalTrials.gov study NCT03426371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
ClinicalTrials.gov study NCT02259556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
ClinicalTrials.gov study NCT04219163. IPD Sharing: NO. Countries: 1. Publications: 0.
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT06353152. IPD Sharing: NO. Countries: 1. Publications: 0.
T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors
ClinicalTrials.gov study NCT02442297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
ClinicalTrials.gov study NCT07224568. IPD Sharing: NO. Countries: 1. Publications: 0.
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
ClinicalTrials.gov study NCT01040000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
ClinicalTrials.gov study NCT04715191. IPD Sharing: NO. Countries: 1. Publications: 0.
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
ClinicalTrials.gov study NCT01954810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06197672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
ClinicalTrials.gov study NCT04815356. IPD Sharing: YES. Countries: 1. Publications: 0.
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
ClinicalTrials.gov study NCT06854159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
ClinicalTrials.gov study NCT01419704. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
ClinicalTrials.gov study NCT05117138. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
ClinicalTrials.gov study NCT04635384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford
ClinicalTrials.gov study NCT05416554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.